SYNTHESIS AND BIOLOGICAL EVALUATION OF SOME NEW BENZOTHIAZOLE DERIVATIVES
HTML Full TextSYNTHESIS AND BIOLOGICAL EVALUATION OF SOME NEW BENZOTHIAZOLE DERIVATIVES
G. J. Upadhaye * and A. J. Asnani
J. L. Chaturvedi College of Pharmacy, Nagpur - 440016, Maharashtra, India.
ABSTRACT: Some new hydrazino group substituted benzothiazole derivatives have been synthesized and their characterization was done by IR, NMR and MASS spectral data. The antimicrobial activities of these synthesized compounds was done by cup-plate diffusion method in DMSO against some Gram positive and Gram negative bacteria. Some of synthesized derivatives exhibited potent activity when compared with standard drug Streptomycin.
Keywords: |
Benzothiazole, Antimicrobial activity, Streptomycin
INTRODUCTION: The chemistry and biological study heterocyclic compounds has been an interesting field for a long time in medicinal chemistry. Benzothaizole derivative are an important class of compounds, which is becoming increasingly important due to their broad spectrum of biological activities. Literature survey shows that many Benzothaizole derivatives are known to exhibit pharmacological activities such as antiviral and antitumor, antiproliferative, antimicrobial, antibacterial, anthelmintic as Cholinesterase inhibitor, antidiabetic, anti-inflammatory, antimalarial, antifungal etc. Hence synthesis of such compounds are of considerable interest. It is well known that the introduction of hydrazine into an organic molecule causes dramatic changes in its biological profile, mainly due to high electronegative atoms substituted on hydrazine and acetophenone causes increase lipid solubility.
Hence, in the present study, some new derivatives of 2-[6-(phenyl) 2-thio 1, 3-oxazin-3yl] amino benzothiazole have been synthesized. Their characterization was done by spectroscopic methods. Further, antimicrobial activities of these derivatives have been studied in DMSO.
Experimental: Reagents grade chemicals were used without further purification. All the melting points were taken in open capillaries and are uncorrected. The purity of the synthesized derivatives was checked by Thin Layer Chromatography.
2.1 Synthesis of substituted 2-hydrazinyl 1, 3-benzothiazole: Take equimolar amount of substituted aniline and conc. hydrochloric acid and triturate it thus solid of salt of Aniline hydrochloride obtained. Mix aniline hydrochloride salt and sulphur into 1:3 proportion respectively stir it continuously by addition of equivalent amount of carbon disulphide in KOH and add 15-20ml of ethanol, reflux it for 5hrs 2-mecaptobenzothiazole obtained, recrystallize with methanol. Take equimolar of 2-mecaptobenzothiazole and hydrazine hydrochloride and add 10-15ml of ethanol stir it and heat mixture at 150-1550C temperature for 2-3hrs, solid mass was obtained which recrystallize from ethanol, to get substituted 2-hydrazinyl 1,3-benzothiazole derivatives.
2.2 Synthesis of 2-[6-(phenyl) 2-thio 1,3-oxazin-3yl] amino benzothiazole derivatives: Take equimolar amount of substituted 2-hydrazinyl 1,3-benzothiazole derivatives and substituted acetophenone in methanol, add 2-4ml of formaldehyde and add few drops of conc. hydrochloride acid with constant stirring and reflux for 2hrs cooled and recrystallize with methanol to get 3-[substituted benzothiazole] hydrazino-1-substituted phenyl propan-1-one. In this add equal amount of sodium borohydride in methanol and constantly stir for 3hrs, stand for overnight, thus solid of 3-[substituted benzothiazole] hydrazino-1-substituted phenyl propan-1-ol gets separated recrystallize with methanol. Take solution 3-[substituted benzothiazole] hydrazino-1-substituted phenyl propan-1-ol in dry chloroform and 2-3ml of carbon disulphide was added dropwise. The resulting mixture was refluxed for 7hrs and distilled-off the excessive solvent. Recrystallized the residue obtained with methanol to get2-[6-(phenyl) 2-thio 1,3-oxazin-3yl] amino benzothiazole derivatives.
TABLE 1: PHYSICAL DATA OF SYNTHESIZED COMPOUNDS
Compounds
Code |
R1 | R2 | Melting
Point |
Rf
Value |
%
Yield |
GS-1 | -H | -OH | 192-194 | 0.57 | 60.4 |
GS-2 | -2Cl | -4NH2 | 201-203 | 0.69 | 65.5 |
GS-3 | -2Cl | -H | 232-234 | 0.75 | 58.0 |
GS-4 | -4Br | -4OH | 202-204 | 0.85 | 40.5 |
GS-5 | -4Br | -H | 175-177 | 0.45 | 58.5 |
GS-6 | -4NO2 | -4NH2 | 166-168 | 0.35 | 73.5 |
GS-7 | -4NO2 | -4OH | 233-235 | 0.84 | 72.5 |
2.3 Spectroscopic study: The characterization of synthesized compounds was done by IR, NMR and MASS spectral data.IR spectra were scanned on SHIMADZU FTIR-8400 Spectrophotometer in frequency range of 4000-400cm-1 by KBr-DRS method. 1H NMR spectral was recorded in DMF with tetramethylsilane(TMS) as the internal standard at 400 MHz on a BRUKER ACF-400 spectrophotometer. The chemical shifts are reported as parts per million (ppm). The mass spectra of synthesized compounds were recorded by GCMS-SHIMADZU-QP2010.
2-[6-(4-Hydroxyphenyl) 2-thio1, 3 – oxazin - 3yl] aminobenzothiazole (GS-1): IR (KBr) (cm-1); 1612.13(ArC=C), 1665.7 & 3402.54 (N-H), 3064.98 & 1456.23(ArCH), 1254.46(C=S), 1779.0(C=O), 3650(CH-OH). 1H NMR (400 MHz) (δppm); 3.69-3.71 (t,4H-CH2), 2.59-2.61 (t, 4H-CH2), 3.33 (s, 2H-CH2), 9.15 (s, 1H-NH), 7.66-7.69 (q, 1H, Ar-H), 7.61-7.64 (dd, 1H, Ar-H), 7.13-7-18 (m, 1H, Ar-H), 1.8 (H-CH2-OH). Mass, m/z; 295 (M+).
2-[6-(4-Aminophenyl) 2-thio1, 3 - oxazin - 3yl] amino 4-chloro benzothiazole (GS-2): IR (KBr) (cm-1); 3253.09 &1600.97 (N-H), 3078.97& 1452.48 (Ar-CH), 1256.81 (C-N), 1358.0 (C=S), 1632.38 (C=O), 1535.39 (ArC=C), 668.31 (H-CH2-Cl). 1H NMR (400 MHz) (δ ppm); 3.68-3.61 (t,4H-CH2), 3.01-3.05 (t, 4H-CH2), 3.12 (s, 2H-CH2), 8.96 (s, 1H-NH), 7.68-7.79 (q, 1H, Ar-H), 6.91-6.94 (dd, 1H, Ar-H), 7.63-7-08 (m, 1H, Ar-H), 2.1 (H-NH), 3.0-3.02 (H-CH2-Cl). Mass, m/z; 370 (M+).
2-[6-(Phenyl) 2-thio 1,3-oxazin-3yl] amino 6-bromo benzothiazole (GS-3): IR (KBr) (cm-1); 3321.08 &1613.23 (N-H), 3099.97& 1398.48 (Ar-CH), 1358.81 (C-N), 1396.10 (C=S), 1701.38 (C=O),1536.39 (ArC=C), 779.01 (H-CH2-Cl). 1H NMR (400 MHz) (δ ppm); 3.73-3.76 (t,4H-CH2), 2.98-3.01 (t, 4H-CH2), 2.91 (s, 2H-CH2), 9.12 (s, 1H-NH), 6.98-7.04 (q, 1H, Ar-H), 6.87-6.92 (dd, 1H, Ar-H), 7.83-7-11 (m, 1H, Ar-H), 3.3-3.51 (H-CH2-Cl). Mass, m/z; 293 (M+).
2-[6-(4-Bromophenyl) 2-thio1, 3 - oxazin-3yl] amino 6-bromo benzothiazole (GS-4): IR (KBr) (cm-1); 3252.09 & 1600.87 (N-H), 3068.98& 1454.54 (Ar-CH), 1300.10 (C-N), 1296.10 (C=S), 1631.38 (C=O),1525.38 (ArC=C), 778.01 (H-CH2-Br), 3401.23(CH-OH). 1H NMR (400 MHz) (δ ppm); 3.34-3.36 (t,4H-CH2), 2.77-2.83 (t, 4H-CH2), 3.51 (s, 2H-CH2), 11.26(s, 1H-NH), 6.98-7.04 (q, 1H, Ar-H), 7.50-7.62 (dd, 1H, Ar-H), 6.83-6-11 (m, 1H, Ar-H), 3.5-3.81 (H-CH2-Br), 1.8 (H-CH2-OH). Mass, m/z; 428 (M+).
2-[6-(Phenyl) 2-thio1,3-oxazin-3yl] amino 6-chloro benzothiazole (GS-5): IR (KBr) (cm-1); 3357.09 & 1608.87 (N-H), 3068.98& 1454.54 (Ar-CH), 1305.85 (C-N), 1319.19 (C=S), 1681.38 (C=O),1562.39 (ArC=C), 698.01 (H-CH2-Br), 3410.23(CH-OH). 1H NMR (400 MHz) (δ ppm); 3.20-3.36 (t,4H-CH2), 2.87-2.98 (t, 4H-CH2), 3.37 (s, 2H-CH2), 11.56(s, 1H-NH), 7.98-8.04 (q, 1H, Ar-H), 7.60-7.72 (dd, 1H, Ar-H), 7.83-6711 (m, 1H, Ar-H), 3.5-3.71 (H-CH2-Cl), 2.0 (H-CH2-OH). Mass, m/z; 298 (M+).
2-[6-(4-Aminophenyl) 2-thio1, 3 - oxazin-3yl] amino 6-nitro benzothiazole (GS-6): IR (KBr) (cm-1); 3254.19 &1600.87 (N-H), 3108.97& 1452.48 (Ar-CH), 1256.81 (C-N), 1368.0 (C=S), 1632.38 (C=O), 1536.49 (ArC=C). 1H NMR (400 MHz) (δ ppm); 3.01-3.06 (t,4H-CH2), 4.01-4.05 (t, 4H-CH2), 3.16 (s, 2H-CH2), 8.96 (s, 1H-NH), 7.58-7.69 (q, 1H, Ar-H), 7.01-7.04 (dd, 1H, Ar-H), 7.96-7-18 (m, 1H, Ar-H), 2.1 (H-NH), 5.2-5.4 (H-CH2-NO2). Mass, m/z; 287 (M+). 2-[6-(4Hydroxyphenyl) 2-thio1, 3 – oxazin - 3yl] amino 6-nitro benzothiazole (GS-7):
IR (KBr) (cm-1); 1612.13 (ArC=C), 1665.7 & 3368.54 (N-H), 3164.98 & 1456.23 (ArCH), 1301.01 (C-N), 1254.46 (C=S), 1669.0 (C=O), 3450 (CH-OH). 1H NMR (400 MHz) (δ ppm); 3.59-3.68 (t,4H-CH2), 2.79-2.84 (t, 4H-CH2), 3.53 (s, 2H-CH2), 10.15 (s, 1H-NH), 7.76-7.80 (q, 1H, Ar-H), 7.61-7.64 (dd, 1H, Ar-H), 7.13-7-18 (m, 1H, Ar-H), 1.8 (H-CH2-OH). Mass, m/z; 295 (M+).
Biological activity: All the synthesized compounds have been screened for in-vitro antibacterial activity against two gram positive bacteria B. Stercothermophilus and S. citrus and two gram negative bacteria E. coli and S. typhi by using cup-plate dilution method, compared with standard drug streptomycin.
3.1 Preparation of solutions: All the synthesized compounds were recrystallized from methanol prior to use. The DMSO used for antimicrobial study was also purified before use bystandard method. For all compounds and standard, solutions of concentration of 10µg/ml were prepared repectively.
3.2 Cup-plate Dilution Method: The antimicrobial evaluation was done by cup-plate dilution method Nutrient agar (Hi-media) medium. The agar cup-plate dilution method was preferred to be used in this study since it was found to be better than the agar disc diffusion method as suggested Parekh et al. The bacterial strains were activated by inoculating a loop full of strain in 10 ml of N-broth and the same was incubated for 24 hrs in an incubator at 370C.
0.1 ml of the activated strain was inoculated in Nutrient agar kept at 450C. It was then poured in the petridishes and allowed to solidify. After solidification of the media, 4-5 mm cup was made in the plates using sterile stainless steel borer. Each cup was filled with 0.1 ml of the test solution. Petri dishes were incubated at 37 °C for 24 hrs. The value obtained for each cup was used to calculate zone of growth inhibition of each sample. The controls were maintained for each bacterial strain, where pure solvent (DMSO) was inoculated into the cup. The inhibition zone formed by these compounds against the particular test bacterial strain determined the antimicrobial activities of the synthetic compounds.
RESULTS AND DISCUSSION:
The purpose of the present work was to synthesize a series of desired title compounds 2-hydrazinyl 1, 3-benzothiazole (GS1-GS7) by reacting hydrazine hydrochloride and substituted 2-mercaptobenzo thiazole. Furthermore, the procedure used commercially available reagents, giving the desired compounds in moderate yields (45-75%). The versatility of this methodology makes it suitable for library synthesis in drug discovery efforts.
The synthesized compounds exhibit antimicrobial activity. Synthetic compounds GS2, GS3, GS4, GS5 have shown significant antimicrobial activity. Compounds GS2 & GS3was most significant. We were pleased to observe significant activity of compound compounds GS2, GS3, GS4, GS5 activity against B. stercothermophilus, S. citrus, E. coli and S. typhi by compared with standard drug streptomycin. While other compounds shown less significant activity. The antimicrobial activity studies have shown in Table 2.
TABLE 2: RESULTS OF ANTIMICROBIAL ACTIVITY (ZONE OF INHIBITION* IN MM, MIC# in ug/ml)
Sr. No. | Compound code | B. stercothermophilus | S. citrus | E. coli | S. typhi |
01 | STD | 34 | 35 | 32 | 36 |
02 | GS1 | 16 | 19 | 21 | 20 |
03 | GS2 | 26 | 25 | 22 | 24 |
04 | GS3 | 27 | 28 | 20 | 29 |
05 | GS4 | 25 | 24 | 21 | 25 |
06 | GS5 | 28 | 24 | 26 | 29 |
07 | GS6 | 18 | 20 | 21 | 17 |
08 | GS7 | 18 | 21 | 19 | 24 |
FIG 1: ANTIMICROBIAL ACTIVITY OF SYNTHETIC COMPOUNDS AGAINST GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA IN DMSO COMPARED WITH STANDARD DRUG STREPTOMYCIN (IN MM)
CONCLUSION: Various benzothiazole derivatives having hydrazinyl substituents and different substituents at position 4 and position 6 of electronegative atoms were synthesized with a view of enhancing the biological activity. The structure of newly synthesized compounds was confirmed by IR, 1NMR, Mass spectra. Further evaluation of antimicrobial activity was carried out. The synthesis of various substituted2-[6-(phenyl) 2-thio 1,3-oxazin-3yl] amino benzothiazole derivatives by the described method resulted in products with good yield. Micro biological evaluation of the synthesized compounds showed good to moderate activity.
ACKNOWLEDGEMENT: The authors are thankful to the authorities of J. L. Chaturvedi college of Pharmacy, Govt. Veternery College, Sharad Pawar College of Pharmacy, Nagpur, Maharashtra, India, and SAIF University Punjab, Chandigarh, India for providing necessary facilities and carrying out IR, NMR, Mass spectra.
REFERENCES:
- Block JH, Baele JM. Wilson and Griswold, “Textbook of organic Medicinal and Pharmaceutical Chemistry”, 8th Ed. Wolterskluwer company. 1982. p. 340.
- G. Vogel, Drug Discovery and Evaluation: Pharmacological Assay, third edition, Springer publication 2008; 692, 1013s, 1103.
- K. Bansal, Heterocyclic Chemistry, fourth edition, New Age International Publication Limited2007; 454-456.
- A. Joule, K. Mills, Heterocyclic Chemistry, fourth edition, Black Well Publishing1978; 21:403-404.
- Wolff M, In; Burger’s Medicinal Chemistry and Drug Discovery “Principles and Practice”, 5th ed. Vol. I, A Wiley-Interscience Publication, John Wiley and Sons, Inc. New York 2004. p. 80.
- The role of Multidrug Efflux Pumps in the Antibiotic Resistance of Pseudomonas aeruginosa and other Gram negative bacteria. Pharmacotherapy. 2003 22(7): 916-924.
- Alekshun MN and Levy S. Molecular Mechanisms of Antibacterial Multidrug Resistance. Cell.2007 128:1037-1050.
- Baquero F and BlàazquezJ. Evolution of Antibiotic Resistance. Trends in Ecology and Evolution.1997 12(12):482-487.
- Berger-Bächi B. Resistance Mechanisms of Gram Positive Bacteria. International Journal of Medical Microbiology. 2002 292:27-35.
- Beta-lactamase inhibitors from laboratory to clinic. Clinical Microbiology Reviews.1988 1(1):10-9-103.
- Courvalin P. The garrod Lecture: Evasion of Antibiotic Action by Bacteria. Journal of Antimicrobial Chemotherapy.1996 37:855-869.
- J. Pelzar, JR., E. C. S. Chan, N. R. Krieg, Microbiology, fifth edition, Tata McGraw hill publication1998; 503-509.
- Vogel AI. Book of elementary practical org. chem. Part-2, 2nd ed. Longman Singapore publisher pvt.ltd; 2001. p. 345-347.
- Stahl E. Thin layer chromatography, 2nd ed. academic press, New York; 1969. p. 904.
- Silverstein RM, spectrometric identification of organic compound, 6th Ed, John Wiley & Sons Inc.; 2004. p. 71-98.
- R., Thakur A.S., Jha A.S. Synthesis and Biological Evaluation of some 1, 3-Benzothiazoles Derivatives. International Journal of Research in Pharmacy and Chemistry2011; 1(3): 223-2781.
- Nadeem Siddiqui, M. Faiz Arshad, Waquar Ahsan, M. Shamsher Alam. Thiazoles: A Valuable Insight into the Recent Advances and Biological Activities. International Journal of Pharmaceutical Sciences and Drug Research 2009; 1(3): 136-143.
- S. Yadav, Devprakash, G.P. Senthilkumar. Benzothiazole: Different Methods of Synthesis and Diverse Biological Activities International Journal of Pharmaceutical Sciences and Drug Research 2001; 3(1): 01-07.
- G. Rajurkar, R. B. Patil, P. B. Miniyar. Synthesis and Antimicrobial Activity of Novel 3, 6-Disubstituted Imidazo [2, 1B] Thiazoles. International Journal of Pharmaceutical Sciences and Research 2011; vol.2 (6), 1537-1542.
- K. Malik, F. V. Manvi, S. Singh. Review of the 2-Amino Substituted Benzothiazoles: Different Methods of the Synthesis. Der Pharmacia Letter 2010; vol.2 (1), 259-347.
- Deshmukh, A. S. Thakur, A. K. Jha. Synthesis and Biological Evaluation of Some 1, 3-Benzothiazole Derivatives. International Journal of Research in Pharmacy and Chemistry 2011; vol.1 (3), 2231-2781.
How to cite this article:
Upadhaye GJ and Asnani AJ: Synthesis and biological evaluation of some new benzothiazole derivatives. Int J Pharm Sci Res 2017; 8(3): 1314-18.doi: 10.13040/IJPSR.0975-8232.8(3).1314-18.
All © 2013 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.